Unusual for a sell side firm to so aggressively question Coca-Cola after reporting good earnings, as sign of the times may be at hand
After delivering what were generally reported as positive earnings last week, Coca-Cola is nonetheless receiving questioning from a sell side analyst.

On the backdrop of good earnings, a Morgan Stanley research piece written by Dara Mohesenian and Bob Doctor calls into question Coca-Cola management, echoing many of the points raised by David Winters, founder of Wintergreen Asset Management and vocal Coke management critic.
In a...

